67.       Zaunders J, Werkmeister J, McCarthy WH, Hersey P. Characterization of antigens recognized by natural killer cells in cell-culture supernatants. Br J Cancer 1981;43:5-12.

66.       Yee KF, McCarthy WH. Warning on phaeochromocytoma. Med J Aust 1981;2:142-3.

65.       Werkmeister J, Phillips G, McCarthy W, Hersey P. Suppressor cell activity in melanoma patients. II. Concanavalin A-induced suppressor cells in relation to tumor growth and suppressor T-cell subsets. Int J Cancer 1981;28:11-5.

64.      Werkmeister J, McCarthy W, Hersey P. Suppressor cell activity in melanoma patients. I. Relation to tumor growth an immunoglobulin levels in vivo. Int J Cancer 1981;28:1-9.

63.       Thompson JF, Little JM. Liver resection for neoplasm. Aust N Z J Surg 1981;51:274-9.

62.       Shaw HM, Milton GW. Smoking and the development of metastases from malignant melanoma. Int J Cancer 1981;28:153-6.

61.       Shaw HM, McGovern VJ, Milton GW, Farago GA. Cutaneous malignant melanoma: occupational and prognosis. Med J Aust 1981;1:37-8.

60.       Roberts G, Martyn AL, Dobson AJ, McCarthy WH. Tumour thickness and histological type in malignant melanoma in New South Wales, Australia, 1970-76. Pathology 1981;13:763-70.

59.       McCarthy WH. Excessive washing and melanoma. Med J Aust 1981;1:716.

58.       Hersey P, Bindon C, Edwards A, Murray E, Phillips G, McCarthy WH. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2. Int J Cancer 1981;28:695-703.

57.       Hall BM, Tiller DJ, Sheil AG, Duggin GG, Horvath JS, Johnson JR, Stephen MS, May J, Rogers JP, Thompson JF, Boulas J. Cyclosporin A in oliguric renal transplant recipients. Lancet 1981;2:876.

56.       Werkmeister J, Zbroja R, McCarthy W, Hersey P. Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro. Clin Exp Immunol 1980;40:168-77.

55.       Werkmeister J, Zaunders J, McCarthy W, Hersey P. Characterization of an inhibitor of cell division released in tumour cell cultures. Clin Exp Immunol 1980;41:487-96.

54.       Shaw HM, McGovern VJ, Milton GW, Farago GA, McCarthy WH. Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer 1980;45:1604-8.

53.       Shaw HM, McGovern VJ, Milton GW, Farago GA, McCarthy WH. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer 1980;46:2731-5.

52.       Milton GW, Shaw HM, Farago GA, McCarthy WH. Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I). Br J Surg 1980;67:543-6.

51.       McGovern VJ, Shaw HM, Milton GW, Farago GA. Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology 1980;4:235-42.

50.       McCarthy WH, Martyn AL, Roberts G, Dobson AJ. Melanoma in new South Wales 1970-1976. Confirmation of increased incidence. Med J Aust 1980;2:137-40.

49.       McCarthy WH, Black AL, Milton GW. Melanoma in New South Wales: an epidemiologic surgery 1970--76. Cancer 1980;46:427-32.

48.       Hersey P, Edwards A, McCarthy WH. Tumour-related changes in natural killer cell activity in melanoma patients. Influence of stage of disease, tumour thickness and age of patients. Int J Cancer 1980;25:187-94.